Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 13 (Search time: 0.002 seconds).
previous
1
2
next
Item hits:
Preview
Issue Date
Title
Author(s)
2018
Asymmetric and symmetric dimethylarginine predict outcomes in patients with atrial fibrillation: an ARISTOTLE substudy
Horowitz, J.
;
De Caterina, R.
;
Heresztyn, T.
;
Alexander, J.
;
Andersson, U.
;
Lopes, R.
;
Steg, P.
;
Hylek, E.
;
Mohan, P.
;
Hanna, M.
;
Jansky, P.
;
Granger, C.
;
Wallentin, L.
2014
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: Insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial
Hijazi, Z.
;
Siegbahn, A.
;
Andersson, U.
;
Granger, C.
;
Alexander, J.
;
Atar, D.
;
Gersh, B.
;
Mohan, P.
;
Harjola, V.
;
Horowitz, J.
;
Husted, S.
;
Hylek, E.
;
Lopes, R.
;
McMurray, J.
;
Wallentin, L.
2014
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial
Wallentin, L.
;
Hijazi, Z.
;
Andersson, U.
;
Alexander, J.
;
De Caterina, R.
;
Hanna, M.
;
Horowitz, J.
;
Hylek, E.
;
Lopes, R.
;
Åsberg, S.
;
Granger, C.
;
Siegbahn, A.
2016
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
De Caterina, R.
;
Andersson, U.
;
Alexander, J.
;
Al-Khatib, S.
;
Bahit, M.
;
Goto, S.
;
Hanna, M.
;
Held, C.
;
Hohnloser, S.
;
Hylek, E.
;
Lanas, F.
;
Lopes, R.
;
López-Sendón, J.
;
Renda, G.
;
Horowitz, J.
;
Granger, C.
;
Wallentin, L.
2016
Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation
Hijazi, Z.
;
Aulin, J.
;
Andersson, U.
;
Alexander, J.
;
Gersh, B.
;
Granger, C.
;
Hanna, M.
;
Horowitz, J.
;
Hylek, E.
;
Lopes, R.
;
Siegbahn, A.
;
Wallentin, L.
2015
Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy
Hijazi, Z.
;
Siegbahn, A.
;
Andersson, U.
;
Lindahl, B.
;
Granger, C.
;
Alexander, J.
;
Atar, D.
;
Gersh, B.
;
Hanna, M.
;
Harjola, V.
;
Horowitz, J.
;
Husted, S.
;
Hylek, E.
;
Lopes, R.
;
McMurray, J.
;
Wallentin, L.
2010
Apixaban for reduction in stroke and other ThromboemboLic events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale
Lopes, R.
;
Alexander, J.
;
Al-Khatib, S.
;
Ansell, J.
;
Diaz, R.
;
Easton, J.
;
Gersh, B.
;
Granger, C.
;
Hanna, M.
;
Horowitz, J.
;
Hylek, E.
;
McMurray, J.
;
Verheugt, F.
;
Wallentin, L.
2012
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial
Lopes, R.
;
Al-Khatib, S.
;
Wallentin, L.
;
Yang, H.
;
Ansell, J.
;
Bahit, M.
;
De Caterina, R.
;
Dorian, P.
;
Easton, J.
;
Erol, C.
;
Ezekowitz, J.
;
Gersh, B.
;
Granger, C.
;
Hohnloser, S.
;
Horowitz, J.
;
Hylek, E.
;
McMurray, J.
;
Mohan, P.
;
Vinereanu, D.
;
Alexander, J.
2014
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin
Hijazi, Z.
;
Wallentin, L.
;
Siegbahn, A.
;
Andersson, U.
;
Alexander, J.
;
Atar, D.
;
Gersh, B.
;
Hanna, M.
;
Harjola, V.
;
Horowitz, J.
;
Husted, S.
;
Hylek, E.
;
Lopes, R.
;
McMurray, J.
;
Granger, C.
2014
Response to letter regarding article, "efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation"
Wallentin, L.
;
Lopes, R.D.
;
Hanna, M.
;
Thomas, L.
;
Hellkamp, A.
;
Nepal, S.
;
Hylek, E.M.
;
Al-Khatib, S.M.
;
Alexander, J.H.
;
Alings, M.
;
Amerena, J.
;
Ansell, J.
;
Aylward, P.
;
Bartunek, J.
;
Commerford, P.
;
De Caterina, R.
;
Erol, C.
;
Harjola, V.P.
;
Held, C.
;
Horowitz, J.
;
et al.
Discover
Author
6
De Caterina, R.
6
Hijazi, Z.
6
McMurray, J.
4
Al-Khatib, S.
4
Ansell, J.
4
Husted, S.
3
Atar, D.
3
Harjola, V.
3
Hohnloser, S.
3
Mohan, P.
.
< previous
next >
Subject
5
Atrial Fibrillation
3
Pyrazoles
3
Pyridones
3
Stroke
3
Warfarin
2
Aged
2
Anticoagulants
2
ARISTOTLE Investigators
2
Atrial fibrillation
2
Hemorrhage
.
next >
Date issued
1
2018
1
2017
2
2016
1
2015
5
2014
1
2013
1
2012
1
2010